Disponible paxil fiable

Abstract

We conducted a systematic review of the efficacy and safety of paxil plus ISRS in acute postoperative convulsions in patients with severe depression. The results were compared with that obtained with placebo in a controlled clinical trial. The mean age of patients was 41.7 ± 13.4 years. Thirty-nine patients received paxil plus ISRS. Patients who were prescribed ISRS had significantly more episodes of convulsions after 8 weeks of treatment (p < 0.001). The mean duration of convulsions was 8.6 ± 1.5 days. The mean interval of arrival in the emergency room was 5.8 ± 1.3 days. In patients without a previous episode of convulsions, the mean duration of convulsions was 6.1 ± 1.2 days.

Our results suggest that patients prescribed ISRS for postoperative convulsions should receive paxil plus ISRS (10 mg daily) and that ISRS is an effective and safe treatment for the first-line treatment of postoperative convulsions.

We used a validated scales for the treatment of postoperative convulsions. The authors recommended that patients who were prescribed ISRS for postoperative convulsions should receive the drug in addition to the standard treatment. A total of 40 patients were randomly assigned to receive paxil plus ISRS or placebo for 8 weeks. The primary endpoint was the difference in the mean duration of convulsions between the groups.

We evaluated the efficacy and safety of paxil plus ISRS in patients with postoperative convulsions.

We reviewed the data obtained in these studies and found that patients prescribed paxil plus ISRS had significantly more episodes of convulsions in comparison to patients prescribed placebo. The mean duration of convulsions was 5.2 ± 1.3 days in the paxil plus placebo group. The mean interval of arrival in the emergency room was 5.8 ± 1.3 days in the paxil plus placebo group.

The results showed that patients prescribed paxil plus ISRS had significantly more episodes of convulsions than patients prescribed placebo. The mean duration of convulsions was 8.6 ± 1.5 days in the paxil plus placebo group.

The present results suggest that patients prescribed paxil plus ISRS are well tolerated. The use of paxil plus ISRS is well tolerated in patients with postoperative convulsions.

Publication types

MeSH terms